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Abstract
OBJECTIVE—To identify trends in the prevalence and epidemiologic correlates of gastroschisis 
using a large population-based sample with cases identified by the National Birth Defects 
Prevention Network over the course of an 11-year period.
METHODS—This study examined 4,713 cases of gastroschisis occurring in 15 states during 
1995–2005, using public use natality data sets for denominators. Multivariable Poisson regression 
was used to identify statistically significant risk factors, and Joinpoint regression analyses were 
conducted to assess temporal trends in gastroschisis prevalence by maternal age and race and 
ethnicity.
RESULTS—Results show an increasing temporal trend for gastroschisis (from 2.32 per 10,000 to 
4.42 per 10,000 live births). Increasing prevalence of gastroschisis has occurred primarily among 
younger mothers (11.45 per 10,000 live births among mothers younger than age 20 years 
compared with 5.35 per 10,000 among women aged 20 to 24 years). In the multivariable analysis, 
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using non-Hispanic whites as the referent group, non-Hispanic black women had the lowest risk of 
having a gastroschisis-affected pregnancy (prevalence ratio 0.42, 95% confidence interval [CI] 
0.37–0.48), followed by Hispanics (prevalence ratio 0.86, 95% CI 0.81–0.92). Gastroschisis 
prevalence did not differ by newborn sex.
CONCLUSIONS—Our findings demonstrate that the prevalence of gastroschisis has been 
increasing since 1995 among 15 states in the United States, and that higher rates of gastroschisis 
are associated with non-Hispanic white maternal race and ethnicity, and maternal age younger 
than 25 years (particularly younger than 20 years of age).
Gastroschisis, a congenital malformation causing the herniation of intestines and other 
abdominal organs outside of the fetal abdominal wall, continues to capture the attention of 
epidemiologists because of ongoing reports of the as-yet-unexplained increase in prevalence. 
Gastroschisis typically results in term or near-term live birth, with few comorbid congenital 
disorders.1–4 Whereas the cause of gastroschisis is unknown, identified risk factors include 
young maternal age with a lower body mass index (calculated as weight (kg)/[height (m)]2)5 
and maternal race and ethnicity.6–8 Compared with foreign-born mothers, mothers born in 
the United States have a higher risk of having a neonate born with gastroschisis.9
Whereas estimates of prevalence of gastroschisis range from 2 to 3 cases per 10,000 live 
births, numerous reports indicate an increasing prevalence both in the United States and 
worldwide.1,8,10–15 Previous United States studies evaluating the trends and correlates of 
gastroschisis have been limited by the relatively rare occurrence. Small case counts may 
have prevented recognition of social, demographic, and clinical factors that might have 
provided information for prevention or intervention efforts. We therefore leveraged 
interstate collaboration within the National Birth Defects Prevention Network to pool data 
from a large, population-based, and nationally representative sample of gastroschisis cases 
over the course of 11 years to address the following research questions: What is the 
prevalence of gastroschisis in the United States?; Is there evidence to show that the 
prevalence has been increasing in the past two decades?; Are there subgroups of women at 
higher risk for having a neonate born with gastroschisis (eg, maternal age, racial, or ethnic 
groups)?; and Are there demographic (eg, sex of the newborn) or reproductive (eg, multiple 
gestations) characteristics associated with the occurrence of gastroschisis?
MATERIALS AND METHODS
This study assessed the prevalence of gastroschisis in 15 states from 1995 to 2005. We 
invited all states with population-based birth defects registries to participate in this project. 
Our only requirements were that they have continuous data from 2005 backward to whatever 
full calendar year was the earliest they could contribute, and that the gastroschisis and 
omphalocele diagnoses were clinically confirmed by medical chart review. Several states 
could not meet these criteria, including large states that relied primarily on hospital 
discharge records with no case confirmation (eg, Illinois, Michigan) and others that for 
administrative reasons did not wish to participate (eg, Hawaii). Massachusetts did not have 
enough years under surveillance. Two states (New Mexico and Washington) were so 
interested in participating that they conducted special projects using active surveillance only 
for gastroschisis cases from 1999 to 2005 so their data could be included in this project.
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Participating states included Arizona, Arkansas, California (select counties), Colorado, 
Georgia (select counties), Iowa, Kentucky, New Mexico, New York, Oklahoma, North 
Carolina, Rhode Island, Texas, Utah, and Washington. All states operated population-based 
birth defects surveillance programs that included gastroschisis in its case definition and were 
willing to provide access to de-identified, individual-level case data. In Georgia and 
California, the programs ascertain all birth defects occurring in women residing in 
catchment areas of contiguous counties. Although states incorporated various case 
ascertainment strategies along the continuum from passive to active surveillance, those 
programs that used passive case-finding strategies performed clinical chart reviews by 
medical personnel to confirm the gastroschisis diagnosis and to differentiate these cases 
from cases of omphalocele. Demographic and perinatal data, including maternal age, 
maternal race and ethnicity, plurality, and sex of the newborn, were obtained for the entire 
study population. Maternal age was categorized into younger than 20 years, 20–24 years, 
25–29 years, 30–34 years, or 35 years and older. Maternal race and ethnicity were 
determined based on maternal self-report and was first grouped by ethnicity (Hispanic or 
non-Hispanic), with the non-Hispanic group further subdivided by race (white, black, Native 
American, Asian or Pacific Islander, and other). Fetal number was grouped into singleton 
and multiple gestation (twins and higher-order) categories.
Birth prevalence of gastroschisis was calculated for each year, state, and category of 
maternal age, race and ethnicity, sex of the newborn, and plurality (fetal number). Cases 
(numerator) consisted of all birth outcomes affected by gastroschisis, including live born 
neonates, fetal deaths, and elective terminations. Population data were based exclusively on 
the total number of live births and were obtained primarily from the National Center on 
Health Statistics. In some instances (California, 1995–2005; Texas 1996–1998), population 
data were obtained from the Office of Vital Statistics of the state. Birth prevalence was 
calculated as the number of gastroschisis cases (of any birth outcome) divided by the total 
number of live births. Live births are used as the denominator; because the true number of 
spontaneous fetal deaths and pregnancy terminations are relatively small in comparison with 
all births, the absence of fetal deaths in the denominator has relatively little effect on the 
final prevalence estimate. Poisson regression was used to generate 95% confidence intervals 
(CIs) for each birth prevalence estimate and to calculate crude prevalence ratios and 95% 
CIs for each covariate (maternal age, maternal race and ethnicity, plurality, and sex of the 
newborn) adjusted for state of residence. A multivariable Poisson regression model with all 
covariates included was used to estimate adjusted prevalence ratios and 95% CIs. To test for 
a linear trend in the gastroschisis prevalence over the course of the study period, we 
included year of delivery as a continuous covariate in the adjusted model. Multivariable 
analyses were initially conducted using an “era” variable to divide the study period into the 
periods 1995–2000 and 2001–2005, but this variable did not contribute to the adjusted 
model and was not included in our final models.
Joinpoint regression analysis was used to identify statistically significant temporal trends of 
gastroschisis prevalence by maternal age and race and ethnicity.16 First, annual trend data 
are modeled by fitting a straight line (ie, zero joinpoints). Next, a model with one joinpoint 
is compared with the null using a Monte Carlo permutation test and, if so, the joinpoint is 
incorporated into the model. An iterative process ensues, and additional joinpoints are 
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considered in the same manner until an optimal-fitting model is selected. Each joinpoint 
represents a statistically significant change (increasing or decreasing) in the temporal trend 
of gastroschisis rates, and an annual percent change and its 95% CI are calculated to 
describe how the rate changes within each time interval. We excluded the “other” race 
category from our joinpoint regression models because there were too few cases to allow for 
a reliable trend analysis.
All statistical tests were two-sided and declared significant at P<.05. Most statistical 
analyses were performed with SAS software 9.2; however, Joinpoint analyses were 
performed using the Joinpoint Regression Program (3.5.4). Approval for the study was 
obtained from the Institutional Review Board at the University of South Florida.
RESULTS
From 1995 to 2005, there were 13,233,776 live births and 4,713 gastroschisis cases among 
the 15 participating states (birth prevalence 3.56 per 10,000 live births). A consistent 
increase in the rate of gastroschisis was noted during the study period, from 2.32 per 10,000 
in 1995 to 4.42 per 10,000 in 2005 (Ptrend <.001; Table 1). Joinpoint regression confirmed 
that a single linear trend provided the best fit to the annual prevalence data. The prevalence 
of gastroschisis for each participating state is presented in Table 2. The lowest rate was 
reported by New York (1.53), and Arkansas had the highest rate of gastroschisis (5.06). 
Differences in prevalence rates between states did not appear to vary consistently based on 
race or ethnicity (data not shown).
The distributions of the study population, birth prevalence, and prevalence ratios for 
gastroschisis by selected maternal and neonate characteristics are presented in Table 3. 
Women younger than 20 years of age had the highest prevalence rate of gastroschisis. 
Among maternal racial and ethnic groupings, mothers reporting “other” race or ethnicity had 
the highest rate of neonates born with gastroschisis (5.47), followed by Native Americans 
(5.48), Hispanics (4.06), and non-Hispanic whites (3.50). Asian or Pacific Islanders and 
non-Hispanic blacks had the lowest rates, 2.20 and 2.25, respectively.
After multivariable analyses adjusting for state of residence (Table 3), women younger than 
age 20 years were 7.2-times more likely to have an offspring with gastroschisis compared 
with women 25–29 years of age (prevalence ratio, 7.18, 95% CI 6.51–7.92), and women 20–
24 years of age were three-times more likely to deliver a newborn with gastroschisis 
(prevalence ratio 3.25, 95% CI 2.95–3.58). As maternal age increased, the risk of 
gastroschisis gradually declined. Compared with non-Hispanic whites, non-Hispanic black 
women had the lowest risk of having a gastroschisis-affected pregnancy (prevalence ratio 
0.42, 95% CI 0.37–0.48), followed by His-panics (prevalence ratio 0.86, 95% CI 0.81–0.92). 
Compared with singleton pregnancies, multiple gestation pregnancies were less likely to be 
affected by gastroschisis (prevalence ratio 0.76, 95% CI 0.60–0.98). Prevalence did not vary 
by newborn sex.
Trends in gastroschisis prevalence rates and the results of the Joinpoint analysis by maternal 
age group and maternal race and ethnicity are shown in Figures 1 and 2. Statistically 
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significant increases in gastroschisis prevalence rates between 1995 and 2005 were seen for 
all maternal age groups younger than 30 years, but not for those 30 years of age and older 
(Fig. 1). Trends also increased significantly for non-Hispanic whites, non-Hispanic blacks, 
and His-panics (Fig. 2). Although not statistically significant, slight increases in prevalence 
rates for Asian or Pacific Islanders and Native Americans were present.
DISCUSSION
In this large population-based study, we addressed three research questions. Our study 
demonstrates a consistent increasing trend in the birth prevalence of gastroschisis in the 
United States during the period 1995–2005. We also confirm a strong inverse association of 
gastroschisis with maternal age and with multiple gestation pregnancy. Crude prevalence 
ratios differed for all racial and ethnic groups analyzed, with lower prevalence among non-
Hispanic black and Asian or Pacific Islanders compared with non-His-panic whites. 
However, after adjustment for maternal age, multiple gestation, and sex of the newborn, 
differences by race and ethnicity were observed only for non-Hispanic black and Hispanic 
mothers compared with non-Hispanic whites.
Our findings support previous findings put forward by several other investigators1,8,11,13,14 
indicating that the prevalence of gastroschisis has been increasing during the past two 
decades in the United States. Consistent with other reports,5–9 this large study also identified 
the maternal risk factors of non-Hispanic ethnicity and white race and age younger than 25 
years (and particularly younger than age 20 years) were associated with higher rates of 
gastroschisis.
Researchers have offered several hypotheses to explain the increasing prevalence of 
gastroschisis in the United States and around the world. Although recreational drug use has 
been proposed as a potential risk factor,17,18 the evidence for this association is limited and 
seems unlikely to account for much of the observed increase in prevalence. Similarly, 
Werler et al19 considered the role of vasoactive medication and Browne et al20 examined 
caffeine intake and found inconsistent evidence in support of the vascular disruption 
hypothesis. Gastroschisis also has been the focus of numerous public health cluster 
investigations, but to date these studies have not yielded insights into risk factors that are 
major drivers of the observed increasing trend.17,21
The primary strengths of this study are the size and breadth of the sample. This large United 
States study includes more than 13 million live births, comprising more than one-third of all 
United States births for most years studied, with data from 15 states generally representative 
of the national population and including considerable racial and ethnic diversity. Data 
regarding gastroschisis cases were obtained from population-based surveillance programs in 
each state, in contrast to clinical studies based on pediatric surgery networks.22 Limitations 
include fewer states participating in the years before 1999, as well as some variability in 
case ascertainment methods. Some states provided data for all cases, including stillbirths and 
terminations, whereas all provided data for cases among live born neonates. We conducted 
sensitivity analyses restricted to years during which all states participated (1999–2005) and 
did not observe significant differences from our findings covering the entire study period. 
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Although every effort was made to identify and exclude cases of amniotic band syndrome 
and limb-body-wall complex, it is possible that a few of these cases were included as 
gastroschisis cases in this study. However, we estimate the number to be less than 1% of all 
cases, so the effect, if any, on our results should be minimal. Although this report includes 
all cases, restricting the analyses to cases among live births did not substantially change the 
statistical findings. Because of inconsistencies in data from several states that resulted in 
large numbers of records with missing data, maternal smoking during pregnancy and parity 
were not examined. With the increasing use of the 2003 revision of the national certificates 
of live birth and fetal death,23 maternal prepregnancy body mass index will become 
available for population-based analysis. Unfortunately, these data elements were not 
sufficiently in use to be included in this study. Future analyses of these data will focus on 
the roles of nativity, birth weight, gestational age, multiple anomalies, and survival patterns.
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Trends in gastroschisis prevalence by maternal age group from 1995 to 2005. Note that the 
average annual change (%) is a point estimate. A. Younger than 20 years of age. B. Age 20–
24 years. C. Age 25–29 years. D. Age 30–34 years. E. Age 35 years or older. CI, confidence 
interval.
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Trends in gastroschisis prevalence by maternal race and ethnicity from 1995 to 2005. Note 
that the average annual change (%) is a point estimate. A. Non-Hispanic white. B. Non-
Hispanic black. C. Hispanic. D. Asian or Pacific Islander. E. American Indian or Alaskan 
Native. Please note a different y-axis scale for the American Indian or Alaskan Native 
group. CI, confidence interval.
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Table 1
Annual Prevalence of Gastroschisis in Selected States in the United States, 1995 to 2005*
Year Crude Cases Total Live Births Prevalence Rate† (95% CI) Prevalence Ratio (95% CI)
1995 173 746,781 2.32 (2.00–2.69) 0.69 (0.58–0.82)
1996 251 851,010 2.95 (2.61–3.34) 0.88 (0.75–1.03)
1997 300 1,010,914 2.97 (2.65–3.32) 0.88 (0.76–1.02)
1998 320 1,015,115 3.15 (2.83–3.52) 0.94 (0.81–1.08)
1999 439 1,307,733 3.36 (3.06–3.69) Reference
2000 489 1,351,074 3.62 (3.31–3.95) 1.08 (0.95–1.23)
2001 492 1,385,485 3.55 (3.25–3.88) 1.06 (0.93–1.20)
2002 525 1,396,345 3.76 (3.45–4.10) 1.12 (0.99–1.27)
2003 539 1,377,989 3.91 (3.59–4.26) 1.17 (1.03–1.32)
2004 564 1,387,787 4.06 (3.74–4.41) 1.21 (1.07–1.37)
2005 621 1,403,543 4.42 (4.09–4.79) 1.32 (1.17–1.49)
Total 4,713 13,233,776 3.56 (3.46–3.66)
CI, confidence interval.
*
States include Arizona, Arkansas, California, Colorado, Georgia, Iowa, Kentucky, New Mexico, New York, Oklahoma, North Carolina, Rhode 
Island, Texas, Utah, and Washington. 1995 does not include Arkansas, Colorado, Kentucky, North Carolina, New Mexico, Texas, Utah, 
Washington; 1996 does not include Arkansas, Colorado, Kentucky, North Carolina, New Mexico, Utah, Washington; 1997 does not include 
Arkansas, Kentucky, North Carolina, New Mexico, Washington; and 1998 does not include Arkansas, North Carolina, and Washington. Data for 
California and Georgia are for selected counties only.
†
Gastroschisis cases per 10,000 live births.
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